Viva Ventures Biotech Fund focuses on investments in global first-in-class, discovery-stage biotech startups with significant growth potential. Viva Ventures is one of very few biotech VCs that have extensive expertise and industry know-how for early stage investments. We have invested more than 20 biotech startups covering diverified indication areas. Among the investments of Fund I started in 2016，there were two M&A exits (one in 2018 with 5.1X return and the other in 2020 with 41.5X return), one IPO in HK in 2019, and one IPO on NASDAQ in 2020 . Extensive industry knowledge and network differentiate us from traditional biotech VCs and enable us to invest in discovery stage to achieve low risk and ultra high investment return.